Usage of Rotarix® in neonatal units across the United Kingdom

Hussain Alsaffar, Katherine Woodger, Ignatius Losa*

*المؤلف المقابل لهذا العمل

نتاج البحث: المساهمة في مجلةمقالمراجعة النظراء


Following advice and recommendations by the Joint Committee on Vaccination and Immunisation (JCVI), and in line with standing commitments on patient rights under the NHS constitution on implementing such recommendations, a series of changes to England's national immunisation programme took place from July 2013 including the introduction of Rotavirus vaccine (Rotarix® by GlaxoSmithKline Biologicals s.a.) into the routine childhood UK schedule for babies from 2 months of age [1].

اللغة الأصليةEnglish
رقم المقال1000240
دوريةJournal of Vaccines and Vaccination
مستوى الصوت5
رقم الإصدار4
المعرِّفات الرقمية للأشياء
حالة النشرPublished - 2014
منشور خارجيًانعم

ASJC Scopus subject areas

  • ???subjectarea.asjc.2700.2723???
  • ???subjectarea.asjc.2400.2403???
  • ???subjectarea.asjc.3000.3002???
  • ???subjectarea.asjc.2400.2406???

قم بذكر هذا